Outsourced Pharma Webinars

  1. Standing Out In The Crowded Biopharma CDMO Market 3/14/2019

    When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection they are able to communicate what is unique about their offering to the right audience at the right time. 

  2. Extractables And Leachables: A Review Of Guidance From The Industry 12/11/2018

    This presentation discusses the basic definitions of extractables and leachables, including details from a case study done using prefilled syringes and a second using a single-use bag.

  3. Cell-Based Assays In A GMP Environment: Approaches For Clinical And Commercial Stability Studies 12/11/2018

    This presentation demonstrates that in vitro, cell-based assays is an indispensable tool to quantify the biological activities, and to support the potency tests, for bio therapeutics.

  4. Optimizing Your Plate-Based Assay Workflows 11/27/2017

    Using workflow based software solutions to guide scientists through various processes in low to high throughput screening campaigns.

  5. Leveraging Machine Learning For Decision Making In The Lab 11/27/2017

    This webinar explores use cases showing how machine learning and analytics can help overcome the challenges facing the biopharma industry through more confident data-driven decisions.

  6. Looking Under The Hood Of The Unified Lab 11/22/2017

    Striving to bring the way we acquire, share and gain insights from scientific data, through a community and the framework for standardization and linked data.

  7. Solvents, Polymers & Cyclones: Bioavailability Enhancement Through Spray-Dried Dispersions 11/2/2017

    Very few new molecular entities in active clinical development are readily bioavailable, and when dosed at escalated levels, even these may not be sufficiently absorbed. Learn how spray-dried amorphous dispersion might help.

  8. Challenges And Opportunities In The Development Of Biologic Drugs 7/20/2017

    With transformational changes in biologics, there are increasingly newer formats of new biologic drugs including bispecific antibodies, antibody drug conjugates and antibody-peptide fusion proteins.

  9. Optimize Biologic Drug Development With The Power Of Scientific Informatics 7/20/2017

    The complex structure of Biologics, the nature of the interactions with their partners, require accurate modelling method to predict their physicochemical properties.

  10. Should Your Next Clinical Trial Use A New Supply Model? 5/26/2017

    Clinical supply models need to provide for an adequate supply of patient kits that allow for variations in patient recruitment levels and clinical site activity.